Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy

NCT00329043 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: LHRH Agonist
DRUG: Sunitinib Malate
PROCEDURE: Radical Prostatectomy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]